Where do we stand with antithrombotic prophylaxis in patients with COVID-19?
- PMID: 32361513
- PMCID: PMC7169902
- DOI: 10.1016/j.thromres.2020.04.023
Where do we stand with antithrombotic prophylaxis in patients with COVID-19?
Conflict of interest statement
Declaration of competing interest The authors do not declare any conflict of interest.
Comment on
-
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10. Thromb Res. 2020. PMID: 32291094 Free PMC article.
References
-
- Zhang T., Sun L.X., Feng R.E., et al. Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(0):E040. - PubMed
-
- Bahloul M., Regaieg K., Dlela M., et al. Pulmonary embolism in intensive care units: more frequent or more known. Clin. Respir. J. 2019;13(8):513–520. - PubMed
